Literature DB >> 19699102

The prognostic value of troponin release after adult cardiac surgery - a meta-analysis.

Giovanna A Lurati Buse1, Michael T Koller, Martin Grapow, Daniel Bolliger, Manfred Seeberger, Miodrag Filipovic.   

Abstract

To assess the accuracy of increased troponin (Tn) concentrations for the prediction of mid-term (> or = 12 months) mortality after coronary artery bypass graft (CABG) and valve surgery, we performed a systematic review identifying all studies reporting on the association between postoperative troponin release and mortality after cardiac surgery. Studies were identified through 30 April 2008 by electronic searches of the MEDLINE, EMBASE and BIOSIS databases. Two reviewers independently selected studies, assessed methodological quality and extracted the data. We primarily considered mid-term (> or = 12 months) and secondarily short-term (< or = 30 days) all-cause mortality. A bivariate random-effects model was used to study determinants and to pool measures of prognostic accuracy of Tn. Seventeen studies fulfilled the inclusion criteria with a total of 237 mid-term deaths in 5189 patients and 296 short-term deaths in 9703 patients. The diagnostic odds ratio of increased Tn concentrations was 5.46 (95% confidence interval (CI) 2.0-14.6) for mid-term mortality and 6.57 (95% CI 4.3-10.1) for short-term mortality after adult cardiac surgery. Alternatively expressed, for troponin elevation, the sensitivity was 0.45 (0.26-0.67) and the specificity 0.87 (0.73-0.90) to predict mid-term mortality. The sensitivity was 0.59 (0.48-0.69) and the specificity 0.82 (0.72-0.89) for short-term mortality. Between-study variability was high. In conclusion, this meta-analysis provides evidence for an association between postoperative Tn release with mid- and short-term all-cause mortality after adult cardiac surgery. However, differences in populations, timing of Tn testing, Tn subunit and Tn assays make definitive conclusions about effect size and cut-off values difficult. Copyright 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19699102     DOI: 10.1016/j.ejcts.2009.05.054

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  21 in total

Review 1.  Periprocedural myocardial enzyme elevation: prognostic implications for current practice.

Authors:  Sanjum S Sethi; Avtar Singh; Michael E Farkouh
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

2.  Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010.

Authors:  Shahram Shahangian; Todd D Alspach; J Rex Astles; Ajay Yesupriya; William K Dettwyler
Journal:  Arch Pathol Lab Med       Date:  2013-06-05       Impact factor: 5.534

3.  Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction.

Authors:  Suresh Govindan; Diederik Wd Kuster; Brian Lin; Daniel J Kahn; Walter P Jeske; Jeanine M Walenga; Fred Leya; Debra Hoppensteadt; Jawed Fareed; Sakthivel Sadayappan
Journal:  Am J Cardiovasc Dis       Date:  2013-06-10

Review 4.  The evolving role of cardiac troponin in the evaluation of cardiac disorders.

Authors:  Paul Anaya; David J Moliterno
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

Review 5.  Cardioprotection during cardiac surgery.

Authors:  Derek J Hausenloy; Edney Boston-Griffiths; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2012-03-22       Impact factor: 10.787

6.  Does lung ischemia and reperfusion have an impact on coronary flow? A quantitative coronary blood-flow analysis with inflammatory cytokine profile.

Authors:  Nikolaos Tsirikos Karapanos; Peter J Wettstein; Zhuo Li; Marianne Huebner; Soon J Park; Claude Deschamps; Stephen D Cassivi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

7.  Myocardial protection with prophylactic oral metoprolol during coronary artery bypass grafting surgery: evaluation by troponin I.

Authors:  João Manoel Rossi Neto; Carlos Gun; Rui Fernando Ramos; Antonio Flavio Sanchez de Almeida; Mario Issa; Vivian Lener Amato; Jarbas J Dinkhuysen; Leopoldo Soares Piegas
Journal:  Rev Bras Cir Cardiovasc       Date:  2013 Oct-Dec

8.  Association of cardiac biomarkers with acute kidney injury after cardiac surgery: A multicenter cohort study.

Authors:  Emilie P Belley-Côté; Chirag R Parikh; Colleen R Shortt; Steven G Coca; Amit X Garg; John W Eikelboom; Peter Kavsak; Eric McArthur; Heather Thiessen-Philbrook; Richard P Whitlock
Journal:  J Thorac Cardiovasc Surg       Date:  2016-02-24       Impact factor: 5.209

9.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

Authors:  Issam D Moussa; Lloyd W Klein; Binita Shah; Roxana Mehran; Michael J Mack; Emmanouil S Brilakis; John P Reilly; Gilbert Zoghbi; Elizabeth Holper; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-10-22       Impact factor: 24.094

10.  Single-center experience with the combination of Cardioplexol™ cardioplegia and MiECC for isolated coronary artery bypass graft procedures.

Authors:  Hendrik Tevaeara Stahel; Silvio Barandun; Emilie Kaufmann; Brigitta Gahl; Lars Englberger; Hansjoerg Jenni; Alberto Weber; Thierry Aymard; Erich Gygax; Thierry Carrel
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.